Interestingly, CRISPR/CAS9 high throughput screening databases (Fig. 3H, www.depMap.org) that allow gene-specific cancer cell fitness assessment have shown SUMO2 to be a pan-cancer fitness gene vs other isoforms. Here, SUMO2 is linked to cancer.